A green tea catechin extract upregulates the hepatic low-density lipoprotein receptor in rats

Lipids

Volumn 42, Issue 7, 2007, Pages 621-627

  Bursill, Christina A ^a,c,d   Roach, Paul D ^b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c CSIRO   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cholesterol absorption; Cholesterol synthesis; Green tea; Lathosterol; LDL receptor; Phytosterols

Indexed keywords

CELLS; CHOLESTEROL; CONCENTRATION (PROCESS); PROTEINS; SYNTHESIS (CHEMICAL);

CHOLESTEROL ABSORPTION; CHOLESTEROL SYNTHESIS; GREEN TEA; LATHOSTEROL; LDL RECEPTOR; PHYTOSTEROLS;

RATS;

CATECHIN; GREEN TEA EXTRACT; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; LIPID ABSORPTION; LIVER CELL; MALE; NONHUMAN; RAT; UPREGULATION;

ADMINISTRATION, ORAL; ANIMALS; ANTICHOLESTEREMIC AGENTS; CATECHIN; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; INTESTINAL ABSORPTION; LIVER; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LDL; TEA; UP-REGULATION;

ANIMALIA; RATTUS;

EID: 34547611881     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-007-3077-x     Document Type: Article

References (33)

1. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47
2. Glass CK, Witztum JL (2001) Atherosclerosis: the road ahead. Cell 104:503-516
3. Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K (1992) Green tea consumption and serum lipid profiles: a cross-sectional study in northern Kyushu, Japan. Prev Med 21:526-531
4. Stensvold I, Tverdal A, Solvoll K, Foss OP (1992) Tea consumption: relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med 21:546-553
5. Imai K, Nakachi K (1995) Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 310:693-696
6. Muramatsu K, Fukuyo M, Hara Y (1986) Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol (Tokyo) 32:613-622
7. Matsuda H, Chisaka T, Kubomura Y, Yamahara J, Sawada T, Fujimura H, Kimura H (1986) Effects of crude drugs on experimental hypercholesterolemia. I. Tea and its active principles. J Ethnopharmacol 17:213-224
8. Yang TT, Koo MW (1997) Hypocholesterolemic effects of Chinese tea. Pharmacol Res 35:505-512
9. Anonymous (2000) Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sci 66:411-423
10. Chan PT, Fong WP, Cheung YL, Huang Y, Ho WK, Chen ZY (1999) Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J Nutr 129:1094-1101
11. Bursill C, Roach PD, Bottema CD, Pal S (2001) Green tea upregulates the low-density lipoprotein receptor through the sterol-regulated element binding protein in HepG2 liver cells. J Agric Food Chem 49:5639-5645
12. Bursill CA, Roach PD (2006) Modulation of cholesterol metabolism by the green tea polyphenol (-)-epigallocatechin gallate in cultured human liver (HepG2) cells. J Agric Food Chem 54:1621-1626
13. Kuhn DJ, Burns AC, Kazi A, Dou QP (2004) Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor. Biochim Biophys Acta 1682:1-10
14. Chisaka T, Matsuda H, Kubomura Y, Mochizuki M, Yamahara J, Fujimura H (1988) The effect of crude drugs on experimental hypercholesteremia: mode of action of (-)-epigallocatechin gallate in tea leaves. Chem Pharm Bull (Tokyo) 36:227-233
15. Ikeda I, Imasato Y, Sasaki E, Nakayama M, Nagao H, Takeo T, Yayabe F, Sugano M (1992) Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta 1127:141-146
16. Bursill CA, Abbey M, Roach PD (2007) A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 193:86-93
17. Huang MT, Ho CT, Wang ZY, Ferraro T, Finnegan-Olive T, Lou YR, Mitchell JM, Laskin JD, Newmark H et al (1992) Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis 13:947-954
18. Clifton PM, Chang L, Mackinnon AM (1988) Development of an automated Lowry protein assay for the Cobas-Bio centrifugal analyser. Anal Biochem 172:165-168
19. Wolthers BG, Walrecht HT, van der Molen JC, Nagel GT, Van Doormaal JJ, Wijnandts PN (1991) Use of determinations of 7-lathosterol (5 alpha-cholest-7-en-3 beta-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis. J Lipid Res 32:603-612
20. Kempen HJ, Glatz JF, Gevers Leuven JA, van der Voort HA, Katan MB, (1988) Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 29:1149-1155
21. Tilvis RS, Miettinen TA (1986) Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 43:92-97
22. Roach PD, Zollinger M, Noel SP (1987) Detection of the low density lipoprotein (LDL) receptor on nitrocellulose paper with colloidal gold-LDL conjugates. J Lipid Res 28:1515-1521
23. Roach PD, Noel SP (1985) Solubilization of the 17 alpha-ethinyl estradiol-stimulated low density lipoprotein receptor of male rat liver. J Lipid Res 26:713-720
24. Roach PD, Kerry NL, Whiting MJ, Nestel PJ (1993) Coordinate changes in the low density lipoprotein receptor activity of liver and mononuclear cells in the rabbit. Atherosclerosis 101:157-164
25. Grundy SM (1991) George Lyman Duff memorial lecture. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease. Arterioscler Thromb 11:1619-1635
26. Albertini R, Moratti R, De Luca G (2002) Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies. Curr Mol Med 2:579-592
27. Steinberg D (1997) Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272:20963-20966
28. Ohashi R, Mu H, Wang X, Yao Q, Chen C (2005) Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM 98:845-856
29. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S) (1994) Lancet 344:1383-1389
30. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial (2002) Lancet 360:7-22
31. Roach PD BS, Hirata F, Abbey M, Szanto A, Simons LA, Nestel PJ (1993) The low-density lipoprotein receptor and cholesterol synthesis are affected differently by dietary cholesterol in the rat. Biochim Biophys Acta 1170(2):165-172
32. Wang S, Noh SK, Koo SI (2006) Epigallocatechin gallate and caffeine differentially inhibit the intestinal absorption of cholesterol and fat in ovariectomized rats. J Nutr 136(11):2791-2796
33. Cornelis MC, El-Sohemy A (2007) Coffee, caffeine, and coronary heart disease. Curr Opin Lipidol 18(1):13-9